Solid Biosciences Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Solid Biosciences Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2018 to Q4 2023.
  • Solid Biosciences Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $91.7M, a 43.9% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $91.7M -$71.9M -43.9% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $164M +$35M +27.2% Dec 31, 2022 10-K 2024-03-13
Q4 2021 $129M +$27.8M +27.6% Dec 31, 2021 10-K 2024-03-13
Q4 2020 $101M +$31.6M +45.6% Dec 31, 2020 10-K 2023-03-23
Q4 2019 $69.2M +$43.9M +174% Dec 31, 2019 10-K 2021-03-15
Q4 2018 $25.3M Dec 31, 2018 10-K 2020-03-12
Q3 2018 $16.7M Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $10M Jun 30, 2018 10-Q 2018-08-10
Q1 2018 $3.29M Mar 31, 2018 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.